Natixis Advisors LLC Sells 41,154 Shares of Agilent Technologies, Inc. (NYSE:A)

Natixis Advisors LLC lowered its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 36.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 72,837 shares of the medical research company's stock after selling 41,154 shares during the period. Natixis Advisors LLC's holdings in Agilent Technologies were worth $9,784,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. CKW Financial Group increased its stake in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after buying an additional 100 shares during the period. Global X Japan Co. Ltd. boosted its holdings in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Hanson & Doremus Investment Management raised its holdings in Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares in the last quarter. OFI Invest Asset Management purchased a new stake in shares of Agilent Technologies in the 4th quarter worth about $37,000. Finally, RPg Family Wealth Advisory LLC purchased a new stake in shares of Agilent Technologies in the 3rd quarter worth about $38,000.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the business's stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company's stock, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the sale, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. The trade was a 8.05 % decrease in their position. The disclosure for this sale can be found here.

Remove Ads

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on A shares. Sanford C. Bernstein decreased their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating for the company in a research note on Tuesday, November 26th. Barclays raised Agilent Technologies from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Bank of America dropped their price target on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research report on Friday, December 13th. StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Finally, Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a report on Monday, December 9th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of "Moderate Buy" and a consensus price target of $146.15.

Agilent Technologies Stock Performance

Shares of A stock traded down $1.62 during trading hours on Tuesday, reaching $120.35. The company had a trading volume of 1,332,640 shares, compared to its average volume of 1,683,755. The firm has a market cap of $34.31 billion, a PE ratio of 27.67, a price-to-earnings-growth ratio of 3.39 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The business has a fifty day moving average price of $136.34 and a 200-day moving average price of $137.16. Agilent Technologies, Inc. has a one year low of $117.17 and a one year high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.82%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies's payout ratio is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.